Predicted Trait | |
Reported Trait | Glioma |
Mapped Trait(s) |
Score Construction | |
PGS Name | GRS7_Glio |
Development Method | |
Name | Genome-wide significant variants |
Parameters | NR |
Variants | |
Original Genome Build | NR |
Number of Variants | 5 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000185 |
Citation (link to publication) | Adel Fahmideh M et al. Sci Rep (2019) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 30,659 individuals (100%) |
PGS Evaluation |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004347 Europe PMC: 28346443 |
30,659 individuals | European | 14 cohorts
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002036 | PSS001009| Multi-ancestry (including European)| 734 individuals |
PGP000185 | Adel Fahmideh M et al. Sci Rep (2019) |
Reported Trait: Pediatric brain tumors | OR: 1.25 [1.06, 1.49] | — | R²: 0.012 | Age, sex, country | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001009 | Cases include participants with the following tumors: Astrocytomas (ICCC-3 group IIIb), Other gliomas (ICCC-3 group IIId), Ependymomas (ICCC-3 group IIIa), Intracranial embryonal tumors (ICCC-3 group IIIc), other specified intracranial neoplasms (ICCC-3 group IIIe), unspecified intracranial neoplasms (ICCC-3 group IIIf) | — | [ ,
54.09 % Male samples |
— | European, NR | European = 454, NR =280 | CEFALO | — |